Product Name: NVP-AUY922 | HSP90 inhibitor
Product Description: NVP-AUY922 is a resorcinol-based, intravenous or intraperitoneal Phase II clinical trial HSP90 inhibitor with a Kd of 1.7 nM. It inhibits tumor cell proliferation at GI50 values of 2-40 nM, inducing G1-G2 arrest and apoptosis. [1] Daily dosing of NVP-AUY9Medchemexpress
Chemical Formula: C26H31N3O5
Molecular Weight: 465.54
‘&“CAS NO: 25316-40-9 Doxorubicin (hydrochloride)
Purity: 99%
Appearance: White
Chemical Name: 5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamideReverse Transcriptase inhibitors
Solubility: Up to 100 mM in DMSO
Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage Condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/12421831